Sapience Investments’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-195,389
Closed -$1.84M 51
2025
Q2
$1.84M Buy
195,389
+13,986
+8% +$123K 1.23% 42
2025
Q1
$1.97M Sell
181,403
-33,017
-15% -$332K 1.41% 28
2024
Q4
$2.04M Sell
214,420
-35,280
-14% -$357K 1.19% 45
2024
Q3
$2.8M Sell
249,700
-740
-0.3% -$7.86K 1.39% 30
2024
Q2
$2.5M Sell
250,440
-92,039
-27% -$935K 1.28% 40
2024
Q1
$3.94M Sell
342,479
-32,870
-9% -$279K 1.31% 41
2023
Q4
$2.74M Sell
375,349
-74,410
-17% -$587K 0.65% 59
2023
Q3
$4.09M Sell
449,759
-8,930
-2% -$107K 0.98% 54
2023
Q2
$5.58M Buy
458,689
+84,180
+22% +$938K 1.26% 45
2023
Q1
$4.66M Sell
374,509
-25,140
-6% -$462K 1.08% 49
2022
Q4
$7.68M Sell
399,649
-13,301
-3% -$281K 1.61% 26
2022
Q3
$7.75M Buy
412,950
+57,480
+16% +$1.18M 1.63% 25
2022
Q2
$6.41M Sell
355,470
-119,310
-25% -$1.94M 1.2% 47
2022
Q1
$7.61M Sell
474,780
-22,600
-5% -$406K 0.92% 59
2021
Q4
$12.2M Buy
497,380
+115,350
+30% +$2.71M 1.39% 40
2021
Q3
$8.9M Buy
382,030
+109,800
+40% +$2.66M 1.06% 55
2021
Q2
$7.46M Buy
+272,230
New +$7.76M 0.93% 63

Other funds holding AHCO

Sapience Investments's AHCO Position: Q3 2025 in Review

Sapience Investments sold out of AdaptHealth (AHCO) in Q3 2025, closing a stake of 195,389 shares — an estimated $1.84M sold.

Sapience Investments first reported a position in AHCO in Q2 2021 and held it in 17 quarters. The position peaked at $12.2M in Q4 2021. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

  • Sapience Investments reported no remaining AdaptHealth position as of Q3 2025 after selling out during the quarter.
  • Sapience Investments sold 195,389 AdaptHealth shares in Q3 2025, an estimated $1.84M.
  • Sapience Investments first reported a position in AdaptHealth in Q2 2021 and held it in 17 quarters.
  • Sapience Investments's AdaptHealth position peaked at $12.2M in Q4 2021.
  • 225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on Sapience Investments's 13F filing for Q3 2025, filed 14 Nov 2025.